KYNTRA BIO, INC. (KYNB) Form 10-Q Quarterly Reports
KYNTRA BIO, INC. (KYNB) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: KYNB
CIK: 921299
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
PricewaterhouseCoopers LLP
Auditor SinceSince 12/31/2016 12:00:00 AM
Lead Engagement PartnerHitean Parmar
Audit LocationIrvine, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-10-06 | 2026-10-01 | 4 Filing | 0001632720-26-000004 | View SEC Doc Filr Page |
| 3 | 2026-10-06 | 2026-10-01 | 3 Filing | 0001632720-26-000003 | View SEC Doc Filr Page |
| 8-K | 2026-10-06 | 2026-09-30 | 8-K | 0001193125-26-415545 | View SEC Doc Filr Page |
| 8-K | 2026-10-01 | 2026-09-30 | 8-K | 0001193125-26-409819 | View SEC Doc Filr Page |
| 4 | 2026-09-09 | 2026-09-06 | 4 Filing | 0001815638-26-000011 | View SEC Doc Filr Page |
| 4 | 2026-09-09 | 2026-09-06 | 4 Filing | 0002040705-26-000007 | View SEC Doc Filr Page |
| 8-K | 2026-08-31 | 2026-08-31 | 8-K | 0001193125-26-377059 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001172661-26-003600 | View SEC Doc Filr Page |
| 10-Q | 2026-08-13 | 2026-06-30 | 10-Q | 0001193125-26-349183 | View SEC Doc Filr Page |
| 8-K | 2026-08-13 | 2026-08-13 | 8-K | 0001193125-26-349141 | View SEC Doc Filr Page |
| 4 | 2026-06-17 | 2026-06-12 | 4 Filing | 0001646395-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-17 | 2026-06-12 | 4 Filing | 0001190642-26-000004 | View SEC Doc Filr Page |
| 4 | 2026-06-17 | 2026-06-12 | 4 Filing | 0001364719-26-000004 | View SEC Doc Filr Page |
| 4 | 2026-06-17 | 2026-06-12 | 4 Filing | 0001420987-26-000004 | View SEC Doc Filr Page |
| 8-K | 2026-06-16 | 2026-06-12 | 8-K | 0001193125-26-271449 | View SEC Doc Filr Page |
| 4 | 2026-06-09 | 2026-06-06 | 4 Filing | 0001815638-26-000009 | View SEC Doc Filr Page |
| 4 | 2026-06-09 | 2026-06-06 | 4 Filing | 0002040705-26-000005 | View SEC Doc Filr Page |
| 8-K | 2026-06-09 | 2026-06-02 | 8-K | 0001193125-26-264000 | View SEC Doc Filr Page |
| 4/A | 2026-05-19 | 2026-05-14 | 4/A Filing | 0001815638-26-000007 | View SEC Doc Filr Page |
| 4 | 2026-05-18 | 2026-05-14 | 4 Filing | 0001815638-26-000005 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-15 | — | SCHEDULE 13G/A Filing | 0001172661-26-002165 | View SEC Doc Filr Page |
| 10-Q | 2026-05-12 | 2026-03-31 | 10-Q | 0001193125-26-219374 | View SEC Doc Filr Page |
| 8-K | 2026-05-11 | 2026-05-11 | 8-K | 0001193125-26-216731 | View SEC Doc Filr Page |
| ARS | 2026-04-27 | 2025-12-31 | ARS | 0001193125-26-182082 | View SEC Doc Filr Page |
| DEFA14A | 2026-04-27 | — | DEFA14A | 0001193125-26-182071 | View SEC Doc Filr Page |